Shockwave Medical to Present at the Canaccord Genuity 40th Annual Growth Conference

Rhea-AI Summary

Shockwave Medical, Inc. (NASDAQ: SWAV) announced its participation in the Canaccord Genuity 40th Annual Growth Conference, set for August 11-13, 2020. The company will host a live fireside chat on August 12, 2020, at 2:30 p.m. Eastern Time, which can be accessed via a webcast on their website. Shockwave Medical specializes in Intravascular Lithotripsy (IVL), a novel technique aimed at improving treatment outcomes for complex calcified cardiovascular disease through sonic pressure waves. For further details, visit their investor relations page.

SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11 to 13, 2020.

Shockwave's management is scheduled for a live fireside chat on Wednesday, August 12, 2020, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the "Investors" section of the company’s website at https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
investors@shockwavemedical.com

FAQ

When is Shockwave Medical's participation in the Canaccord Genuity conference?

Shockwave Medical will participate in the Canaccord Genuity 40th Annual Growth Conference from August 11 to 13, 2020.

What time is Shockwave Medical's fireside chat during the conference?

The fireside chat is scheduled for August 12, 2020, at 2:30 p.m. Eastern Time.

Where can I access the webcast for Shockwave Medical's conference presentation?

The webcast can be accessed on the 'Investors' section of Shockwave Medical's website.

What technology does Shockwave Medical develop for cardiovascular treatment?

Shockwave Medical develops Intravascular Lithotripsy (IVL), a technique using sonic pressure waves to treat calcified plaque in cardiovascular disease.

What is the stock symbol for Shockwave Medical?

The stock symbol for Shockwave Medical is SWAV.